These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 18716553)
21. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas. Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical markers for prognosis of ependymal neoplasms. Korshunov A; Golanov A; Timirgaz V J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959 [TBL] [Abstract][Full Text] [Related]
23. Correlation of bcl-2, p53, and MIB-1 expression with ependymoma grade and subtype. Rushing EJ; Brown DF; Hladik CL; Risser RC; Mickey BE; White CL Mod Pathol; 1998 May; 11(5):464-70. PubMed ID: 9619600 [TBL] [Abstract][Full Text] [Related]
24. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China. Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163 [TBL] [Abstract][Full Text] [Related]
25. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review. Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537 [TBL] [Abstract][Full Text] [Related]
26. Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study. Chen X; Li C; Che X; Chen H; Liu Z Acta Neurochir (Wien); 2016 Jan; 158(1):101-7. PubMed ID: 26577638 [TBL] [Abstract][Full Text] [Related]
27. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors. Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489 [TBL] [Abstract][Full Text] [Related]
28. Does Gross Total Resection Improve Progression-Free and Overall Survival in Pediatric Intracranial Ependymomas? Single-Center Clinical Experience Of 61 Cases. Narin F; Bahadir S; Hanalioğlu Ş; Karakaya D; Başar I; Işikay I; Söylemezoğlu F; Akalan N; Bilginer B World Neurosurg; 2022 Sep; 165():e469-e478. PubMed ID: 35772712 [TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of cell cycle/apoptosis regulators and epidermal growth factor receptor in pediatric intracranial ependymomas. Alexiou GA; Stefanaki K; Moschovi M; Patereli A; Prodromou N; Karentzou O J Child Neurol; 2011 Feb; 26(2):195-8. PubMed ID: 20713981 [TBL] [Abstract][Full Text] [Related]
30. Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Guyotat J; Metellus P; Giorgi R; Barrie M; Jouvet A; Fevre-Montange M; Chinot O; Durand A; Figarella-Branger D Acta Neurochir (Wien); 2009 Aug; 151(8):947-60. PubMed ID: 19499166 [TBL] [Abstract][Full Text] [Related]
31. Radiotherapy in addition to surgical resection may not improve overall survival in WHO grade II spinal ependymomas. Brown DA; Goyal A; Takami H; Graffeo CS; Mahajan A; Krauss WE; Bydon M Clin Neurol Neurosurg; 2020 Feb; 189():105632. PubMed ID: 31862631 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of Ki-67 (MIB-1) and p53 in ependymomas. Suzuki S; Oka H; Kawano N; Tanaka S; Utsuki S; Fujii K Brain Tumor Pathol; 2001; 18(2):151-4. PubMed ID: 11908872 [TBL] [Abstract][Full Text] [Related]
33. Prognosis by tumor location in adults with spinal ependymomas. Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515 [TBL] [Abstract][Full Text] [Related]
34. [Intracranial ependymomas in adult patients. Diagnosis and histological prognostic factors]. Figarella-Branger D; Metellus P; Barrié M; Maues de Paula A; Fernandez C; Polivka M; Vital A; Labrousse F; Vignaud JM; Laquerrière A; Rousselet MC; Lacroix C; Saikali S; Chapon F; Gontier MF; Chrétien F; Babin P; Rigau V; Vandenbos F; Peoc'h M; Kujas M; Chinot O; Gouvernet J; Giorgi R; Guyotat J; Jouvet A Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):76-84. PubMed ID: 17445840 [TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of localization and grading in intracranial ependymomas of childhood. Ernestus RI; Schröder R; Stützer H; Klug N Childs Nerv Syst; 1996 Sep; 12(9):522-6. PubMed ID: 8906366 [TBL] [Abstract][Full Text] [Related]
36. [Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study]. Metellus P; Barrie M; Figarella-Branger D; Chinot O; Giorgi R; Jouvet A; Guyotat J Neurochirurgie; 2007 Jun; 53(2-3 Pt 1):66-75. PubMed ID: 17475290 [TBL] [Abstract][Full Text] [Related]
37. Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases. Stephen JH; Sievert AJ; Madsen PJ; Judkins AR; Resnick AC; Storm PB; Rushing EJ; Santi M J Neurosurg Pediatr; 2012 Jun; 9(6):646-53. PubMed ID: 22656257 [TBL] [Abstract][Full Text] [Related]
38. The Effects of Surgery and Adjuvant Therapy on Survival Outcomes in Clear Cell Ependymomas: A Systematic Review and Meta-Analysis of Individual Patient Data. Sheen Kweh BT; Rosenfeld J; Hunn M; Tee JW World Neurosurg; 2021 Jan; 145():229-240. PubMed ID: 32949795 [TBL] [Abstract][Full Text] [Related]
39. [Therapeutic results of eight patients with intracranial ependymomas]. Sasajima T; Takahashi M; Kinouchi H; Suzuki A; Mizoi K No To Shinkei; 2003 Mar; 55(3):233-40. PubMed ID: 12728504 [TBL] [Abstract][Full Text] [Related]
40. [Brain tumors in infants and children--factors affecting prognosis. (Part 1) Ependymoma (author's transl)]. Oi S; Raimondi AJ No Shinkei Geka; 1980 Nov; 8(11):1049-55. PubMed ID: 7453936 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]